Paramel Infusion Injection (L-Aspartate-L-Ornithine)
L-Ornithine-L-Aspartate 500mg
Injections · Prescription medication
Korea Pharma Co., Ltd.
MFDS item code 201605972 · Notified 2016.10.10
Detoxification treatment for severe liver disease (hepatic encephalopathy)
This medication is used to detoxify symptoms ranging from pre-comatose states to coma caused by hepatic encephalopathy due to severe liver disease. Hepatic encephalopathy occurs when liver function is impaired, affecting brain function, and this medication can improve symptoms. Thus, it aids in the treatment of comatose states in patients with severe liver disease.
As L-Aspartate-L-Ornithine, up to 40 g (8 ampoules) per day can be mixed with appropriate intravenous solutions and administered by drip infusion. Adjust dosage accordingly based on symptoms.
This medication comes in a glass ampoule, so care must be taken when opening the container to avoid glass shards entering. Special attention should be given when using this medication for children and the elderly. This medication should not be used in patients with certain conditions. For example, it should not be used in cases of lactate acidosis, methanol poisoning, individuals who cannot properly digest fructose and sorbitol, certain enzyme deficiency patients, and those with severe renal dysfunction. Additionally, this medication contains sodium pyrosulfite, which can cause allergic reactions in some individuals. Patients with asthma may be particularly sensitive to this component, so caution is advised. Use of this medication may sometimes lead to a sensation of heat in the back of the neck, nausea, discomfort in the stomach, or vomiting. When administered in high doses, urea levels in the blood and urine should be monitored to check the body's condition. Patients with compromised liver function should adjust the infusion rate to reduce discomfort or vomiting. It is important to administer this medication slowly by intravenous injection. Lastly, keep this medication out of the reach of children, and do not transfer it from the original container to another container. This helps maintain the quality of the medication and prevents misuse.
Asthma attacks, severe allergic reactions such as sulfite anaphylaxis
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in a container that blocks light, and the temperature should be kept between 1 to 30 degrees Celsius at room temperature. Proper storage will safely maintain the medication's effectiveness.
A solution that is colorless to pale yellow in a brown ampoule
<Domestic> 10mL X 25 ampoules <Export> 10mL X 25 ampoules, 10mL X 10 ampoules
Even with the same ingredient, strength, dosage form and how it is taken can differ.
L-Ornithine-L-Aspartate 500mg
Injections · Prescription medication
Korea Pharma Co., Ltd.
L-Ornithine-L-Aspartate 500mg
Prescription medication
Hanwha Pharmaceutical Co., Ltd.
L-Ornithine-L-Aspartate 5g
Prescription medication
Hanwha Pharm Co., Ltd.
L-Ornithine-L-Aspartate 3g
OTC medication
Hanwha Pharmaceutical Co., Ltd.
L-Ornithine-L-Aspartate 5g
Injections · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
L-Ornithine-L-Aspartate 500mg
Injections · Prescription medication
Daewon Pharmaceutical Co., Ltd.
L-Ornithine-L-Aspartate 500mg
Solution · Prescription medication
Korea Union Pharmaceutical Co., Ltd.
L-Ornithine-L-Aspartate 500mg
Prescription medication
Daehan Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.